IPHARMA is a contract research organization focusing on conducting clinical trials of investigational drugs developed by Russian and International pharmaceutical and biotech companies in Russia and EAEU. IPHARMA is a member of ChemRar High-Tech Center group of companies and an accredited partner of Skolkovo Innovation Center.
Our pipeline consists of over 120 clinical trials in oncology, virology, endocrinology, pulmonology, neurology, transplantology, etc. We provide agile clinical services in both early-phase and registration trials, as well as medical, regulatory, and PV expertise to ensure optimal timeline for your drug development. According to Association of Clinical Trials Organizations, IPHARMA has been ranked as a market leader of Russian innovative drugs. (ACTO Analytical report #8 for 2013, #10 for 2014, #12 for 2015, #14 for 2016, #16 for 2017 and #18 for 2018).